期刊
ONCOLOGY REPORTS
卷 33, 期 6, 页码 2863-2870出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/or.2015.3924
关键词
microRNA; hepatocellular carcinoma; hepatitis B virus; cirrhosis
类别
资金
- Natural Science Foundation of Jiangsu Province, China [BK2011151]
- Medical Project of the Health Department, Jiangsu Province [11201248]
- Preventive Medicine Research Projects of Jiangsu Province [Y2012016]
- Social Development Project of Zhenjiang City [SH201346]
Circulating microRNAs (miRNAs) exist stably in body fluids and are potential biomarkers for hepatocellular carcinoma (HCC). Twenty-five patients with cirrhosis that evolved into HCC, who were treated at The Third Hospital of Zhenjiang Affiliated to Jiangsu University between January 2005 and December 2012, were enrolled. In the discovery stage, 2 serum samples pooled from 3 cirrhosis and 3 HCC samples were subjected to deep sequencing. Subsequently, differential expression of miRNAs was validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) in the serum samples from an independent cohort of 22 patients with cirrhosis and HCC. Twenty-two miRNAs showed a >2-fold upregulation (P<0.01), and 2 miRNAs showed a >2-fold downregulation (P<0.01) in the cirrhosis and HCC samples. Using the comparative Ct method, we calculated the 2(-Delta Delta Ct) for 40 candidate miRNAs in the sample sets. Eight of the 40 miRNAs demonstrated significantly differential expression levels between the disease categories. The miRNAs exhibiting differential expression were hsa-miR-122-5p, hsa-miR-199a-5p, hsa-miR-486-5p, hsa-miR-193b-5p, hsa-miR-206, hsa-miR-141-3p, hsa-miR-192-5p and hsa-miR-26a-5p. We identified the miRNAs differentially expressed in cirrhosis that evolved into hepatitis B virus-related HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据